SCHEMBL4771680

SCHEMBL4771680

CCCNc1ncccc1C(=O)OC

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.71
ALDH1A1 P00352 3/20 0.71
HPGD P15428 2/20 0.71
HSD17B10 Q99714 1/20 0.71
CNR2 P34972 1/20 0.50
RAB9A P51151 1/20 0.48
HTT P42858 2/20 0.48
POLB P06746 1/20 0.48
TDP1 Q9NUW8 2/20 0.48
PKM P14618 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
BDKRB1 P46663 3/20 0.47
MEN1 O00255 2/20 0.46
MAPT P10636 2/20 0.46
KMT2A Q03164 2/20 0.46
MAP2K1 Q02750 1/20 0.46
GLA P06280 2/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7437816 0.91 ALDH1A1 (0.59) KDM4EALDH1A1HPGDHSD17B10CNR2
SCHEMBL6612663 0.88 ALDH1A1 (0.68) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL11492008 0.88 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10CNR2
SCHEMBL8826118 0.84 KDM4E (0.75) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL22731793 0.83 ALDH1A1 (1.00) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL11607709 0.81 KDM4E (0.48) KDM4EALDH1A1HPGDHSD17B10CNR2
SCHEMBL6605329 0.80 HTT (0.60) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL9591599 0.79 CNR2 (0.48) KDM4EALDH1A1HPGDHSD17B10CNR2
SCHEMBL5871444 0.79 PKM (0.58) KDM4EALDH1A1HPGDRAB9ATDP1
SCHEMBL8692447 0.79 KDM4E (0.68) KDM4EALDH1A1HPGDHSD17B10RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2002837-A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2008-12-17 EP disclosed
EP-1741713-A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists Bristol-Myers Squibb Company (US) 2007-01-10 EP disclosed
EP-1237888-B1 BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2006-09-13 EP disclosed
US-6852745-B2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2005-02-08 US disclosed
US-6835741-B2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists BRISTOL-MYERS SQUIBB COMPANY 2004-12-28 US disclosed
US-6638937-B2 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer BRISTOL-MYERS SQUIBB CO. 2003-10-28 US disclosed
EP-1172109-A1 COMPOSITIONS FOR PREVENTING AND TREATING TYPE I ALLERGY Sunstar Inc. (JP) 2002-01-16 EP disclosed
EP-1172443-A1 METHOD FOR SCREENING CYSTEINE PROTEASE INHIBITOR YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2002-01-16 EP disclosed